HP
LLY icon

Hilltop Partners’s Eli Lilly LLY Stock Holding History

Hilltop Partners’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.52M Buy
6,268
+377
+6% +$385K 1.82% 16
2026
Q1 		$5.42M Buy
5,891
+384
+7% +$389K 1.39% 17
2025
Q4 		$5.92M Buy
5,507
+1,559
+39% +$1.49M 1.53% 16
2025
Q3 		$3.01M Buy
3,948
+1,618
+69% +$1.2M 0.9% 28
2025
Q2 		$1.82M Buy
2,330
+597
+34% +$464K 0.55% 33
2025
Q1 		$1.43M Sell
1,733
-10
-0.6% -$8.32K 0.48% 36
2024
Q4 		$1.35M Buy
1,743
+497
+40% +$412K 0.46% 35
2024
Q3 		$1.1M Buy
1,246
+63
+5% +$56.6K 0.37% 37
2024
Q2 		$1.07M Buy
1,183
+208
+21% +$166K 0.4% 38
2024
Q1 		$758K Buy
975
+71
+8% +$50.5K 0.27% 56
2023
Q4 		$527K Buy
904
+418
+86% +$244K 0.21% 60
2023
Q3 		$261K Buy
486
+15
+3% +$7.73K 0.11% 83
2023
Q2 		$221K Buy
+471
New +$198K 0.09% 90

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Hilltop Partners's LLY Position: Q2 2026 in Review

Hilltop Partners increased its Eli Lilly (LLY) stake by 6.4% in Q2 2026, buying an estimated $385K and bringing the position to 6,268 shares worth $7.52M. The position accounts for 1.82% of the portfolio, ranked #16.

Hilltop Partners first reported a position in LLY in Q2 2023 and has held it in 13 quarters since. 4,623 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Hilltop Partners held 6,268 shares of Eli Lilly worth $7.52M as of Q2 2026.
  • Hilltop Partners bought 377 Eli Lilly shares in Q2 2026, an estimated $385K.
  • Eli Lilly made up 1.82% of Hilltop Partners's portfolio in Q2 2026, its #16 holding.
  • Hilltop Partners first reported a position in Eli Lilly in Q2 2023 and has held it in 13 quarters since.
  • 4,623 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Hilltop Partners's 13F filing for Q2 2026, filed 5 Aug 2026.